3D-Printed Demineralized Bone Matrix Hydrogels for Craniofacial Bone Tissue Regeneration.
3D-Printed Demineralized Bone Matrix Hydrogels for Craniofacial Bone Tissue Regeneration.
批准号:
10261420
负责人:
Katie Hogan
金额:
$4.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-09 至 2023-09-08
关键词:
3D PrintAlkaline PhosphataseArchitectureAutologous TransplantationBiochemicalBiocompatible MaterialsBlood VesselsBone MatrixBone RegenerationBone ResorptionBone TissueCalciumCellsCleft PalateClinicalComplexCongenital AbnormalityCuesDentalDental ImplantationDevicesDiseaseEnsureExcisionExtracellular MatrixGeometryGoalsGrowth FactorHeightHistologyHydrogelsImplantIn VitroInfectionKineticsLeadMeasuresMembraneMesenchymal DifferentiationMesenchymal Stem CellsModelingMorbidity - disease rateNatural regenerationOperative Surgical ProceduresParietal bone structurePatientsPeriodontal DiseasesPorosityProceduresPropertyRattusResearchResearch Project GrantsRiskRoleSiteSwellingTestingTimeTissue EngineeringTissuesTooth DiseasesTooth ExtractionTranslationsTraumaWorkalveolar bonebonebone qualityclinically relevantcraniofacialcraniofacial bonecraniofacial tissuecrosslinkdemineralizationdensitydesignhydrogel scaffoldimprovedin vivoin vivo Modelin vivo regenerationinfection rateinsightmechanical propertiesmicroCTnanoparticleosteogenicpalate repairreconstructionscaffoldstandard carestem cell proliferationtissue regenerationtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
There is a clinical need for craniofacial bone augmentation in cases of trauma, tumor resection, congenital
malformations, or bone resorption as a result of tooth extraction or periodontal disease. Currently, bone autograft,
which is associated with increased risk of donor site morbidity and infection, and non-resorbable barrier
membranes, which required additional procedures for removal, are the standard of treatment. Therefore, the
objective of this research is to develop 3D printed scaffolds for craniofacial bone augmentation using a clinically
relevant material, demineralized bone matrix, for guided bone regeneration. The fundamental hypothesis for this
research project is that the endogenous biochemical cues for bone regeneration found within demineralized
bone matrix combined with the ability to tune scaffold microarchitecture and crosslinking via 3D printing will result
in improved bone augmentation.
Two specific aims will be investigated to accomplish the goals of this project. In the first specific aim, we
will fabricate 3D-printed scaffolds composed of demineralized bone matrix nanoparticles with varied pore sizes
and UV crosslinking times. The mechanical properties and degradation kinetics of these scaffolds will then be
characterized via compressive testing, bulk swelling, and mass loss studies. Additionally, the in vitro osteogenic
potential of the demineralized bone matrix scaffolds will be evaluated using mesenchymal stem cells and
measured by alkaline phosphatase expression, calcium content, and markers of osteogenic differentiation. The
results of this specific aim will elucidate the role of pore size and UV crosslinking in determining the osteogenic
potential of demineralized bone matrix scaffolds and determine which groups are appropriate for in vivo
translation. In the second specific aim, we will investigate the in vivo osteoinductive and osteoconductive capacity
of 3D-printed demineralized bone matrix scaffolds. The scaffolds will be implanted in a rat parietal bone
augmentation model for 12 weeks and assessed via micro-CT and histology for newly formed bone volume,
maximum bone height, and bone quality.
Upon completion of the proposed work, we will have determined the in vitro and in vivo bone regeneration
efficacy of an acellular, 3D-printed demineralized bone matrix scaffold and demonstrated tunability of scaffold
mechanical properties and degradation. Additionally, the proposed work provide new insights into rational 3D-
printed scaffold design and fabrication for craniofacial applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3D-Printed Demineralized Bone Matrix Hydrogels for Craniofacial Bone Tissue Regeneration.
-
批准号:10451625
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2020
-
负责人:Katie Hogan
-
依托单位:
海外基金